Status:

COMPLETED

Adjacent Segment Disease After Anterior Cervical Decompression Surgery

Lead Sponsor:

Zuyderland Medisch Centrum

Collaborating Sponsors:

Maastricht University Medical Center

Conditions:

Adjacent Segment Disease

Cervical Myelopathy

Eligibility:

All Genders

18+ years

Brief Summary

Radiculopathy and/or myelopathy due to cervical degenerative disc disease are increasingly common pathologies in our ageing population. Both can be treated non-surgically or surgically. The most commo...

Detailed Description

1. SUMMARY Radiculopathy and/or myelopathy due to cervical degenerative disc disease are increasingly common pathologies in our ageing population. Both can be treated non-surgically or surgically. The...

Eligibility Criteria

Inclusion

  • Patients with symptomatic single-level or multi-level radiculopathy and/or myelopathy due to CDDD, which corresponds to the afflicted level on radiologic imaging.
  • Neurosurgical technique used: anterior cervical discectomy (simple discectomy, ACD), anterior cervical discectomy with fusion (ACDF) with or without plating, corpectomy.
  • Minimum age 18 years.
  • Adequately documented treatment.
  • Follow up data available in electronic patients records for at least one outpatient follow-up visit weeks post-operative

Exclusion

  • Any other cause than degenerative disc disease for radiculopathy and/or myelopathy such as compression by spinal tumours, trauma, infection or rheumatologic pathologies.
  • Objection to participate in scientific research.

Key Trial Info

Start Date :

March 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2020

Estimated Enrollment :

673 Patients enrolled

Trial Details

Trial ID

NCT04320043

Start Date

March 1 2020

End Date

October 1 2020

Last Update

November 18 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Zuyderland Medisch Centrum

Heerlen, Limburg, Netherlands, 6419 PC